CD38 and Miyoshi myopathy: It binds to CD38 on MM cells, exerts its ectoenzyme hydrolytic activity to generate metabolites that regulate intracellular calcium levels and activate purinergic receptors, thereby leading to cell lysis and immune-mediated tumor suppression.